BUSINESS
Mid-day Mood | Trade remains tepid as investors book profit, eye on FOMC meet
Analysts believe inflation print and the US Federal Reserve's policy outcome will drive the next course of equity action.
BUSINESS
Mid-day Mood | Sensex scales 70,000 even as action remains lacklustre
The momentum was much stronger in the broader market as the Nifty Smallcap 100 jumped 0.8 percent while the Nifty Midcap 100 rose 0.4 percent.
BUSINESS
Samir Arora extremely bullish on largecap financials, says share prices to pick up in 2024
HDFC Bank remains Samir Arora's all-time favourite, making up 8.9 percent of Helios Capital's total assets under management
BUSINESS
Cheer on the Street as Nifty hits 21,000; gains 2% for the week
RBI also raised its GDP growth forecast for FY24 to 7.0 percent from 6.5 percent, which ushered further optimism among investors.
BUSINESS
Analyst call tracker: Sun Pharma among analysts’ top picks on speciality, domestic sales boost
Sun Pharma's presence in the global speciality space is its biggest asset, which, along with its superior execution in the domestic market and a recovery in US sales, will power its growth, analysts have said
BUSINESS
Mid-day Mood | Market takes a breather as investors book partial profits; Nifty near 20,900
In the past seven sessions, the Nifty surged nearly 6 percent while the Sensex gained around 5 percent, giving investors an opportunity to take home partial profits.
BUSINESS
Indian market more sensitive to growth, liquidity than valuation: Rashesh Shah
Edelweiss Group chairman Rashesh Shah also believes that incremental FII inflows will come to India once interest rates in the US start coming down
BUSINESS
Rupee hits record low, but why are exporters not celebrating?
Companies in sectors like IT, pharma, chemicals, oil marketing and textiles generally gain when the rupee falls. This time, the story is different. Analysts explain why.
BUSINESS
Nifty nears 21,000-mark on sustained rally; IT stocks, Adani & RIL hot picks
Going by the strong bullish trend, most analysts suggest investors use every decline as a 'buying-on-dip' opportunity
BUSINESS
Nifty extends bull run to 6th session to climb 20,800; Bank Nifty crosses 47,000 for first time
Nifty Bank also extends its stellar gains from the previous session and rise another percent to scale a new high of 46,933.15
BUSINESS
Why Nifty, Bank Nifty hit all-time highs? What drives biggest single-day gains since Oct 2022
Experts feel that the recent mandate have thrown a positive surprise for the markets, which sees a greater probability of the continuation of existing government policies beyond 2024. The Nifty and Sensex have surged around 14% year-to-date
BUSINESS
Nifty poised for new highs in December F&O series as long rollovers rise, FIIs cover shorts
Analysts expect the strong momentum for the Nifty on the back of strong rollovers, positive FII sentiment and upbeat global and domestic cues to take it to newer all-time highs in the December F&O series.
BUSINESS
BJP sweep powers Nifty, Sensex to new highs; 4 factors fuelling the rally
The BJP's strong showing in three Hindi heartland states has given a strong message of continued policy support while easing concerns over political stability and fiscal profligacy, say analysts
BUSINESS
Why Sensex lags behind Nifty in race to new highs? Blame it on these top gainers BSE index lacks
The Nifty 50 scaled a fresh record high of 20,285.15 earlier in the day while the Sensex is still 400 points shy of its all-time peak.
BUSINESS
Mid-day Mood | Indices trade marginally down but two listings steal the show
Some volatility was also seen in trade as traders rushed in to rollover positions ahead of the expiry of the November derivatives series, slated at market close today.
BUSINESS
Mid-day Mood | Adani Group stocks spike in lacklustre market; Nifty trades flat
Benchmark indices mirrored the subdued trend seen across global markets.
BUSINESS
Domestic pharma sales bounce back in October as favourable base comes into play
Sales in the domestic pharma market finally turned around in October on the back of an increase in acute sales amid an uptick in viral infections
BUSINESS
Two key risks to India economy: Morgan Stanley tells what could derail growth in 2024
India's growth is likely to remain resilient in 2024 amid strong domestic demand and a robust capex cycle. However, RBI's cautious interest rate regime and the impending general elections in 2024 will be the key factors maneuvering the country's growth trajectory.
BUSINESS
Nifty jumps 1.2%, Sensex 750 points: Easing inflation, positive cues and all that fuelled the rally
A softer-than-expected US inflation print for October fueled hopes of the Fed pivoting its rate hike campaign, ushering gains across global markets.
BUSINESS
Strong pharma Q2 earnings lift Nifty Pharma index up 6% in seven straight sessions
Q2 earnings of most drugmakers topped the Street's expectations despite modest growth in acute sales within the domestic pharma market.
BUSINESS
Apollo Hospitals Q2 Preview: Better occupancy, lower spends to drive growth for HealthCo
Lower spends towards scaling up of the company's Apollo 24/7 business is likely to aid growth in Q2.
BUSINESS
Mid-day Mood: Indices trade flat amid volatility; Pharma, oil stocks shine
The small and mid-cap indices outperformed their large-cap peers on the back of several companies reporting solid growth in Q2.
BUSINESS
Alkem Labs' better-than-expected Q2 results impresses brokerages, prompts positive outlook
Alkem Laboratories delivered an earnings beat in Q2 with its net profit, revenue as well as profitability topping the Street's estimates.
BUSINESS
Divi's Labs fails to cheer up brokerages with weak Q2 results, sharp margin contraction
Divi's Laboratories reported an on year slump in its net profit and operating margin while revenue growth remained muted in Q2.
